A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Clinical trial NCT07037771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07037771
Sponsor: Arrowhead Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia

Start date: 2025-06-17
Primary completion: 2027-08-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.